Helene Depui Ekdal
Plus aucun poste en cours
Profil
Ms. Helene Depui Ekdal was previously employed as a Senior Director by AstraZeneca AB and a Director-Clinical Development by Egetis Therapeutics AB.
She received her graduate degree from Chalmers University of Technology and an MBA from Handelshögskolan i Göteborg.
Anciens postes connus de Helene Depui Ekdal
| Sociétés | Poste | Fin |
|---|---|---|
| EGETIS THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | 01/06/2023 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01/01/2019 |
Formation de Helene Depui Ekdal
| Chalmers University of Technology | Graduate Degree |
| Handelshögskolan i Göteborg | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
